📈 Jumpstart Signal Watchlist — July 24, 2026

🏢 What they do: Paysign, Inc. is a payments technology company that provides prepaid card programs, integrated payment processing, and digital banking/payment solutions for businesses, healthcare and pharmaceutical clients, and government or consumer payout programs.
- 🎯 Current $8.69 is 5% below 3yr high $9.12 · ⏳ SMA200 $5.62 (current price $8.69 is above) · 💰 Market Cap $484M
- PAYS passed all filters and shows favorable conditions.

💎 Quality (Q): 53/60
- 🏦 EMA21 above EMA50; EMA uptrend sustained 5+ days; EPS growth 80% (>20%); Revenue growth 51% (>15%); ROE 19% (>15%); Low LT D/E 0.08 (<1.0).
⏰ Entry (E): 0/20
- 🔔 Strong above EMA50 (13.0%)
- 🔔 VWMA trending up (5 consecutive days)
📢 Sentiment (S): 5/10
- 🗞️ News sentiment is neutral (mixed coverage).
✅ Paysign (NASDAQ:PAYS) Hits New 12-Month High — MarketBeat.
🤖 A new 12-month high suggests strong recent price momentum and favorable market sentiment toward the stock. The piece also notes Buy ratings and a consensus Buy view, which supports a positive stock reaction.
❌ Paysign EVP Joan Herman sells $517,662 in company stock — Investing.com.
🤖 The article reports insider selling by an executive, which is often viewed as a cautious signal for investors. It does not describe any offsetting operational improvement, so the immediate readthrough for $PAYS is mildly negative.
⚪️ Paysign to Host Second Quarter 2026 Earnings Call — Business Wire.
🤖 This is only a scheduling announcement for a future earnings call and does not provide results, guidance, or analyst commentary. Per your instructions, it should not be treated as substantive stock news, so the impact is neutral.
🍭 Bonus (B): 0/10 — Business Services

🏢 What they do: Bioventus Inc. is a global medical device company that develops and commercializes clinically proven, minimally invasive products to relieve pain and address musculoskeletal challenges by enhancing the body's natural healing process .
- 🎯 Current $11.80 is 14% below 3yr high $13.71 · ⏳ SMA200 $8.62 (current price $11.80 is above) · 💰 Market Cap $794M
- BVS shows decent technicals supported by positive sentiment.

💎 Quality (Q): 43/60
- 🏦 EMA21 above EMA50; EMA uptrend sustained 5+ days; EPS growth 200% (>20%); ROE 15% (>15%); Near-high ROE setup (52wk high + ROE); PEG ratio 0.14 (<1.5).
⏰ Entry (E): 0/20
- 🔔 Strong above EMA50 (12.5%)
- 🔔 VWMA trending up (5 consecutive days)
📢 Sentiment (S): 10/10
- 🗞️ News sentiment is positive.
✅ Bioventus Inc. (NASDAQ:BVS) Given Average Rating of "Buy" by Brokerages — MarketBeat.
🤖 Analysts covering Bioventus assigned an average rating of Buy and a consensus 1-year price target of $14.75, which is supportive for the stock. The article also notes more buy ratings than hold ratings among the six firms covered.
✅ Bioventus shares rise after Medicare reverses reimbursement cuts — Investing.com.
🤖 Bioventus shares jumped after CMS reversed previously issued reimbursement cuts for the company’s non-invasive bone growth stimulators. That change improves the reimbursement backdrop for an important product category and is favorable for revenue expectations.
🍭 Bonus (B): 0/10 — Surgical & Medical Instruments

🏢 What they do: Exelixis is an oncology-focused biotechnology company that discovers, develops, and commercializes medicines for hard-to-treat cancers. Its main products include CABOMETYX (cabozantinib), COMETRIQ (cabozantinib), and COTELLIC (cobimetinib), and it also advances a pipeline of small molecules and biotherapeutics for cancer treatment.
- 🎯 Current $55.37 is 3% below 3yr high $57.10 · ⏳ SMA200 $45.19 (current price $55.37 is above) · 💰 Market Cap $14.0B
- EXEL shows decent technicals supported by positive sentiment.

💎 Quality (Q): 56/60
- 🏦 Low drawdown (9.8% max); EMA21 above EMA50; EMA uptrend sustained 5+ days; EPS growth 44% (>20%); ROE 43% (>15%); Low LT D/E 0.00 (<1.0).
⏰ Entry (E): 0/20
- 🔔 VWMA trending up (5 consecutive days)
- 📈 RSI at 55 in healthy mid-range
📢 Sentiment (S): 8/10
- 🗞️ News sentiment is positive.
✅ Exelixis Inc stock hits all-time high at 56.22 USD — Investing.com.
🤖 The article says EXEL reached an all-time high and was trading near that peak, reflecting strong recent price momentum. It also notes analyst updates and trial-related developments that the piece frames as supportive of investor confidence.
✅ EXEL Stock Soars 26.8% in Three Months: Is There More Room for Growth? — Yahoo Finance.
🤖 This article highlights EXEL’s strong three-month outperformance versus the broader market and sector. It also characterizes the stock favorably and points to zanzalintinib as a key growth driver.
⚪️ Exelixis (EXEL) Stock Price, News & Analysis - NASDAQ — MarketBeat.
🤖 This is a stock overview page rather than a fresh company-specific news item, but it shows EXEL trading near the top of its range with a hold consensus. Because it is largely descriptive and not a discrete catalyst, the impact is neutral.
⚪️ Arrowstreet Capital Limited Partnership Decreases ... — MarketBeat.
🤖 This is mainly an institutional-holding update combined with a recap of recent analyst opinions and prior earnings results. It does not introduce a new company-specific catalyst strong enough to be clearly positive or negative.
🍭 Bonus (B): 10/10 — Biological Products (Biotech sector)

🏢 What they do: Concentra Group Holdings Parent, Inc. is a provider of occupational health services in the United States, focused on helping employers manage workplace injuries and employee health. Its services include occupational health centers, onsite employer clinics, telemedicine, workers’ compensation care, and other direct-to-employer health services.
- 🎯 Current $31.61 is 1% below 3yr high $31.91 · ⏳ SMA200 $23.10 (current price $31.61 is above) · 💰 Market Cap $4.0B
- CON shows decent technicals supported by positive sentiment.

💎 Quality (Q): 56/60
- 🏦 Low drawdown (13.6% max); EMA21 above EMA50; EMA uptrend sustained 5+ days; EPS growth 30% (>20%); ROE 42% (>15%); Low LT D/E 0.00 (<1.0).
⏰ Entry (E): 0/20
- 🔔 Strong above EMA50 (10.1%)
- 🔔 VWMA trending up (5 consecutive days)
- 📈 RSI at 64 showing strength
📢 Sentiment (S): 10/10
- 🗞️ News sentiment is positive.
✅ Concentra Standout in Occupational Medicine: Analyst - Concentra Group Holdings (NYSE:CON) — Benzinga.
🤖 This analyst-focused piece is positive for $CON because it highlights favorable commentary on the company’s occupational medicine position and notes that the shares were up 3.26% and trading at a new 52-week high at publication.
🍭 Bonus (B): 0/10 — Specialty Outpatient Facilities

🏢 What they do: John Wiley & Sons, Inc. (Wiley) is a global research and learning company that publishes over 1,900 peer-reviewed scientific, technical, medical, and scholarly journals along with academic and professional books, encyclopedias, and digital content .
- 🎯 Current $49.55 is 7% below 3yr high $53.13 · ⏳ SMA200 $37.69 (current price $49.55 is above) · 💰 Market Cap $2.6B
- WLY shows decent technicals supported by positive sentiment.

💎 Quality (Q): 56/60
- 🏦 Low drawdown (8.3% max); EMA21 above EMA50; EMA uptrend sustained 5+ days; EPS growth 103% (>20%); ROE 26% (>15%); Low LT D/E 0.81 (<1.0).
⏰ Entry (E): 0/20
- 🔔 VWMA trending up (5 consecutive days)
- 📈 RSI at 54 in healthy mid-range
📢 Sentiment (S): 8/10
- 🗞️ News sentiment is positive.
✅ Hillsdale Investment Management Inc. Increases Stake in John Wiley & Sons, Inc. (WLY) — MarketBeat.
🤖 An institutional investor increasing its stake is generally a constructive signal for the stock because it suggests continuing professional investor interest in WLY.
⚪️ John Wiley & Sons (WLY) 10K Form and Latest SEC Filings 2026 — MarketBeat.
🤖 This filing page is a general SEC-filings hub rather than a specific market-moving story, so it does not provide a clear bullish or bearish catalyst for WLY.
🍭 Bonus (B): 0/10 — Book Publishing

🏢 What they do: BrightSpring Health Services (BTSG) is a leading provider of comprehensive home and community-based health services, including clinical, nonclinical, pharmacy, and ancillary care, to complex populations across all ages and skill levels. It operates as the parent company of brands focused on specialized care in home and community settings, emphasizing quality outcomes for people with complex needs.
- 🎯 At/above 3yr high $72.91 (current $72.91) · ⏳ SMA200 $44.83 (current price $72.91 is above) · 💰 Market Cap $14.1B
- BTSG shows decent technicals supported by positive sentiment.

💎 Quality (Q): 53/60
- 🏦 Low drawdown (9.3% max); EMA21 above EMA50; EMA uptrend sustained 5+ days; EPS growth 379% (>20%); Revenue growth 26% (>15%); ROE 16% (>15%).
⏰ Entry (E): 0/20
- 🔔 Strong above EMA21 (5.3%)
- 🔔 Strong above EMA50 (13.6%)
- 🔔 VWMA trending up (5 consecutive days)
- 📈 RSI at 65 showing strength
📢 Sentiment (S): 10/10
- 🗞️ News sentiment is positive.
✅ BTSG Stock Gains on Q1 Earnings & Revenue Beat, 2026 Outlook Raised — Zacks.
🤖 BrightSpring reported a first-quarter earnings and revenue beat, and management raised its 2026 revenue outlook. That combination is generally supportive for the stock because it signals stronger-than-expected operating performance and improved forward guidance.
✅ مניית BTSG מגיעה לשיא כל הזמנים של $70.99 — Investing.com (Israel).
🤖 This article says BTSG hit an all-time high near $70.99 and was trading only slightly below its 52-week high. New price highs are typically positive for sentiment because they reflect strong recent demand for the shares.
🍭 Bonus (B): 0/10 — Home Health Care Services

🏢 What they do: Host Hotels & Resorts, Inc. (HST) is the world's largest publicly traded lodging real estate investment trust (REIT). It owns a geographically diverse portfolio of luxury and upper-upscale hotels, primarily in top U.S. markets, and is the largest third-party owner of Marriott and Hyatt hotels.
- 🎯 Current $24.50 is 2% below 3yr high $25.13 · ⏳ SMA200 $19.82 (current price $24.50 is above) · 💰 Market Cap $16.8B
- HST shows decent technicals supported by positive sentiment.

💎 Quality (Q): 51/60
- 🏦 Low drawdown (9.4% max); EMA21 above EMA50; EMA uptrend sustained 5+ days; EPS growth 106% (>20%); Low LT D/E 0.19 (<1.0); PEG ratio 0.16 (<1.5).
📢 Sentiment (S): 10/10
- 🗞️ News sentiment is positive.
✅ Sei Investments Co. Purchases 64078 Shares of Host Hotels & Resorts, Inc. (HST) — MarketBeat.
🤖 This filing-focused article reports a new institutional purchase of HST shares, which is typically interpreted as a bullish signal for investor confidence. The article also notes a 'Moderate Buy' consensus and target price, reinforcing a positive tone for the stock.
✅ Host Hotels & Resorts (NASDAQ:HST) Price Target Raised to $25.00 — MarketBeat.
🤖 A higher price target is constructive for HST because it implies improved analyst expectations for the stock’s value. The article also references a 'Moderate Buy' consensus, which supports a positive read-through.
✅ Host Hotels Gains 18.8% in Three Months: Will the Trend Last — Zacks.
🤖 The article highlights strong recent share-price momentum, with HST up 18.8% over three months. That trend is generally supportive for sentiment, even though the piece is more of a performance commentary than a catalyst-driven company update.
🍭 Bonus (B): 0/10 — REITs